Sunday, September 23, 2018

CLIFF NOTES FOR OVCA RESEARCH


TAKING A BREAK FROM CHEMOTHERAPY
I kid you not.  She was incredible.

Here is a handy summary of the state of our war against ovarian cancer, as of the moment.  Short, sweet, but not too complete.  (See, I am a poet, although you didn’t know it.)


To benefit from this blurb you  may need to be reminded of the nature and function of PARP inhibitors.  If so, give this a try:


1 comment:

  1. This may be a bit too specialized for the likes of us, but if you have OVCA let us hope that your oncologist knows this stuff:

    https://www.onclive.com/onclive-tv/dr-campos-discusses-differences-between-parp-inhibitors-in-recurrent-ovarian-cancer

    ReplyDelete